a study of middle age to elderly men (53-68) found that a three month administration of cjc 1295 resulted in a lean body mass improvement in these men an average of over 15 pounds
Largo, FL (PRWEB) October 17, 2012
CJC 1295 is an amino acid chain comprised of 30 amino acids that acts as a growth hormone releasing hormone (GHRH). Numerous studies have concluded that this peptide is effective for increasing IGF 1 (insulin like growth factor) in patients during research studies.
As an example a study of middle age to elderly men (53-68) found that a three month administration of cjc 1295 resulted in a lean body mass improvement in these men an average of over 15 pounds during the test. These types of results are promising considering the age of the men and future uses may include anti-aging treatments.
Scientists that have interest in bio conjugation should have significant interest in CJC-1295. There is technology available that modifies the peptide to extend the half-life. Typically CJC 1295 has a half-life of just 10 minutes in the body but with the addition of DAC (drug affinity complex) the half-life of the peptide is extended to up to eight days. In addition serum IGF 1 levels remained elevated for 9-11 days after a single dose of the peptide.
US Peptides is proud to offer high quality research grade peptides like CJC-1295 for research purposes.
USPeptides.com is a United States based distributor of the highest grade research Peptides and Amino Acid Derivatives available. We utilize the most advanced techniques to ensure fast and secure product delivery. These items are intended for research purposes only.